The anticancer properties of a series of mononuclear Re(IV) compounds of formula ReCl4L (where L is bpy=2,2'-bipyridine; bpym=2,2'-bipyrimidine; dmbpy=4,4'-dimethyl-2,2'-bipyridine; phen=1,10-phenanthroline) were investigated for the first time. All compounds displayed potent in vitro antiproliferative activity against selected cancer cells.
Rhenium(IV) compounds inducing apoptosis in cancer cells
Lappano R;RUSSO, Nino;MAGGIOLINI, Marcello;DE MUNNO, Giovanni
2011-01-01
Abstract
The anticancer properties of a series of mononuclear Re(IV) compounds of formula ReCl4L (where L is bpy=2,2'-bipyridine; bpym=2,2'-bipyrimidine; dmbpy=4,4'-dimethyl-2,2'-bipyridine; phen=1,10-phenanthroline) were investigated for the first time. All compounds displayed potent in vitro antiproliferative activity against selected cancer cells.File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
